Why the study?
Does aortic valve replacement prevent sudden death and heart failure in asymptomatic adult patients with severe aortic stenosis?
Does aortic valve replacement prevent sudden death and heart failure in asymptomatic adult patients with severe aortic stenosis?
Challenges the conventional wisdom of watchful waiting in asymptomatic severe aortic stenosis, advocating for early valve replacement in patients with specific high-risk markers to prevent irreversible fibrosis and sudden death.
Answers are grounded in this paper and cite their sources.
May support early AVR consideration in high-risk asymptomatic severe AS; leaves open confirmation by randomized trials before practice change.
Presently, conventional wisdom is that an asymptomatic patient, even with severe aortic stenosis (AS), can be followed medically. The basis for this recommendation is that sudden death as the first "symptom" in an asymptomatic patient is rare. Unfortunately, symptoms are subjective and can be ignored or explained away by both patient and physician, and once symptoms are recognized, sudden death accounts for at least one third of the deaths from AS in unoperated patients. There is evidence that once AS becomes severe, ischemia and fibrosis occur rapidly, setting up the possibility of heart failure and sudden death even after successful valve replacement. Aortic valve replacement should be performed before extensive fibrosis occurs. Multiple studies have shown that in severe AS, symptoms will occur rapidly when there is heavy valve calcification, an aortic valve area <0.8 cm, an annual rate of progression of aortic valve velocity of >/=0.3 m/sec, or a positive exercise stress test. These findings are excellent evidence that asymptomatic patients with severe AS and any of the above findings should be considered for aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Melvin D. Cheitlin (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: